Drug Profile
K 111
Alternative Names: BM 170744Latest Information Update: 19 Aug 2015
Price :
$50
*
At a glance
- Originator Roche Diagnostics
- Developer Kowa
- Class Antihyperglycaemics; Lauric acids; Small molecules
- Mechanism of Action Peroxisome proliferator-activated receptor alpha agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Hyperlipidaemia; Type 2 diabetes mellitus